Redefining Tuberculosis: Lalita Ramakrishnan’s Work Transforms Understanding of TB Infection
Tuberculosis (TB), one of the world’s deadliest infectious diseases, is being re-examined through groundbreaking research led by Lalita Ramakrishnan at the MRC Laboratory of Molecular Biology. Her work is reshaping how scientists understand TB infection, host susceptibility, and treatment resistance.
🔬 A New Way to Study TB
A major innovation from Ramakrishnan’s lab is the use of the zebrafish model to study tuberculosis in living organisms. This system allows researchers to:
- Visualize infection in real time using fluorescently labeled bacteria
- Study interactions between host immune cells and TB bacteria
- Experiment with combinations of host and bacterial genetic mutations
This approach provides an unprecedented window into how Mycobacterium tuberculosis behaves inside a living host—something that traditional models struggle to capture.
🧠 Key Insights from the Research
Ramakrishnan’s work has revealed several critical aspects of TB biology:
- TB progression is not solely determined by the bacteria, but also by host genetic factors
- Immune cells like macrophages can unintentionally aid bacterial survival
- Certain mechanisms allow bacteria to develop drug tolerance, even during active treatment
These findings challenge long-standing assumptions about TB and highlight why the disease remains difficult to treat.
💊 Implications for Treatment and Drug Resistance
The research also sheds light on drug resistance mechanisms, including how TB bacteria use efflux pumps—molecular systems that expel antibiotics—to survive inside host cells.
Importantly, studies from the group have shown that:
- Existing drugs (including some repurposed ones) may help block these resistance pathways
- Understanding host–pathogen interactions could lead to more effective combination therapies
🌍 Why This Matters
According to the World Health Organization, tuberculosis continues to be a major global health challenge. Insights from this research could:
- Improve early detection and treatment strategies
- Help design more effective anti-TB drugs
- Provide a better understanding of latent TB and disease progression
🤝 A Collaborative Scientific Effort
Now based in Cambridge, Ramakrishnan continues to collaborate with scientists worldwide, integrating expertise from structural biology, biochemistry, and genetics. This interdisciplinary approach is key to tackling a complex disease like TB.
🔭 The Bigger Picture
By combining innovative models like zebrafish with advanced genetic tools, this research represents a shift toward real-time, systems-level understanding of infectious diseases.
It not only redefines tuberculosis biology but also sets a precedent for studying other complex infections in the future.
Source: https://new.express.adobe.com/webpage/GdOanITcUxt0i/
Explore more
🎤 Career – Real career stories and job profiles of life science professionals. Discover current opportunities for students and researchers.
💼 Jobs – The latest job openings and internship alerts across academia and industry.
🛠️ Services – Regulatory support, patent filing assistance, and career consulting services.
